<bill session="109" type="h" number="4131" updated="2023-01-13T04:49:53Z">
  <state datetime="2005-10-25">REFERRED</state>
  <status>
    <introduced datetime="2005-10-25"/>
  </status>
  <introduced datetime="2005-10-25"/>
  <titles>
    <title type="display">Public Health Emergency Medicines Act</title>
    <title type="official" as="introduced">To amend title 35, United States Code, to provide for compulsory licensing of certain patented inventions relating to health care emergencies, and to provide that applications under section 505 of the Federal Food, Drug, and Cosmetic Act that are submitted pursuant to such licenses may be approved with immediate effective dates.</title>
    <title type="short" as="introduced">Public Health Emergency Medicines Act</title>
  </titles>
  <sponsor bioguide_id="B000944"/>
  <cosponsors>
    <cosponsor bioguide_id="A000357" joined="2005-10-25"/>
    <cosponsor bioguide_id="B000420" joined="2005-10-25"/>
    <cosponsor bioguide_id="K000336" joined="2005-10-25"/>
    <cosponsor bioguide_id="N000002" joined="2005-10-25"/>
    <cosponsor bioguide_id="S000810" joined="2005-10-25"/>
    <cosponsor bioguide_id="W000215" joined="2005-10-25"/>
  </cosponsors>
  <actions>
    <action datetime="2005-10-25">
      <text>Introduced in House</text>
    </action>
    <action datetime="2005-10-25" state="REFERRED">
      <text>Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2005-10-25">
      <text>Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2005-11-04">
      <text>Referred to the Subcommittee on Health, for a period to be subsequently determined by the Chairman.</text>
    </action>
    <action datetime="2006-02-06">
      <text>Referred to the Subcommittee on Courts, the Internet, and Intellectual Property.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSJU" name="House Judiciary" subcommittee="" activity="Referral"/>
    <committee code="HSJU03" name="House Judiciary" subcommittee="Courts, Intellectual Property, and the Internet" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="109" type="h" number="4102" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Commerce"/>
    <term name="Access to health care"/>
    <term name="Commercialization"/>
    <term name="Compensation (Law)"/>
    <term name="Drug approvals"/>
    <term name="Drug industry"/>
    <term name="Drugs"/>
    <term name="Economics and Public Finance"/>
    <term name="Emergency Management"/>
    <term name="Exports"/>
    <term name="Federal aid to research"/>
    <term name="Foreign Trade and International Finance"/>
    <term name="Health"/>
    <term name="Intellectual property"/>
    <term name="Inventions"/>
    <term name="Law"/>
    <term name="Licenses"/>
    <term name="Medical supplies"/>
    <term name="Medical technology"/>
    <term name="Patents"/>
    <term name="Pharmaceutical research"/>
    <term name="Product development"/>
    <term name="Public health"/>
    <term name="Research grants"/>
    <term name="Restrictive trade practices"/>
    <term name="Risk"/>
    <term name="Science, Technology, Communications"/>
    <term name="Technology transfer"/>
    <term name="World health"/>
  </subjects>
  <amendments/>
  <summary date="2005-12-06T18:55:02Z" status="Introduced in House">Public Health Emergency Medicines Act - Gives the Secretary of Health and Human Services the right to authorize use of the subject matter of a patent relating to health care without authorization of the patent holder if the Secretary determines that the invention is needed to address a public health emergency. Provides for reasonable remuneration for the patent holder for use of the patent.

Allows the Secretary to authorize the use of a patent, without the patent holder's authorization, to export medicines or other health care products that are needed to address global public health emergencies when the legitimate rights of the patent holder are protected in the export market.

Authorizes the Secretary to immediately approve a new drug application upon request by a person authorized to manufacture the drug under this Act.</summary>
</bill>
